TPST
TPST
NASDAQ · Biotechnology

Tempest Therapeutics Inc

$1.94
+0.00 (+0.00%)
As of May 16, 2:30 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,153.6% upside
Low Target $35.70
Average Target $43.72
High Target $58.20
Current Price $1.94
Current
$1.94
Target
$43.72
$35.70 $43.72 avg $58.20
Scenario Analysis
Bear Case
$35.70
1,740.2%
Low target
Base Case
$43.72
+2,153.6%
Avg target
Bull Case
$58.20
+2,900.0%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$12.23
-84.1% from high
52-Week Low
$1.50
+29.3% from low
Target vs 52W High
$43.72
+257.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%